Skip to main content
Livermore
Livermore
ZHEN

Ritholtz Wealth Management

SEC CIK
0001698218
Latest filing
Aug 11, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Ritholtz Wealth Management, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2026)
1,770
Value
$1.10M
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of REGN by Ritholtz Wealth Management, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,770$1.10M<0.1%+362+25.7%AddedHolders
Q1 20261,408$1.09M<0.1%+172+13.9%AddedHolders
Q4 20251,236$954.1K<0.1%+1,236NewHolders
Q3 20250$00.0%−386−100.0%Sold outHolders
Q2 2025386$202.7K<0.1%−100−20.6%ReducedHolders
Q1 2025486$308.1K<0.1%+35+7.8%AddedHolders
Q4 2024451$321.3K<0.1%−278−38.1%ReducedHolders
Q3 2024729$766.4K<0.1%+109+17.6%AddedHolders
Q2 2024620$651.6K<0.1%+54+9.5%AddedHolders
Q1 2024566$544.8K<0.1%+69+13.9%AddedHolders
Q4 2023497$436.5K<0.1%−13−2.5%ReducedHolders
Q3 2023510$419.7K<0.1%+79+18.3%AddedHolders
Q2 2023431$309.7K<0.1%−64−12.9%ReducedHolders
Q1 2023495$406.7K<0.1%−16−3.1%ReducedHolders
Q4 2022511$368.7K<0.1%−1,056−67.4%ReducedHolders
Q3 20221,567$1.08M0.1%+858+121.0%AddedHolders
Q2 2022709$419.0K<0.1%+41+6.1%AddedHolders
Q1 2022668$467.0K<0.1%+63+10.4%AddedHolders
Q4 2021605$382.0K<0.1%+3+0.5%AddedHolders
Q3 2021602$364.0K<0.1%−41−6.4%ReducedHolders
Q2 2021643$359.0K<0.1%+10+1.6%AddedHolders
Q1 2021633$299.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.